Michael Pepe is currently a Sr. Manager in Analytical Development at AbbVie, a role they assumed in 2024 following AbbVie's acquisition of ImmunoGen, Inc., where they previously served as a Sr. Manager. Prior to this, they held the position of Supervisor in Analytical Method Transfer and were involved in various roles within quality control technical support at ImmunoGen. Michael's career began at OPK Biotech, LLC, where they worked as an analyst. They earned a Bachelor's degree in Chemistry from Boston University in 2009.
This person is not in the org chart
This person is not in any teams
This person is not in any offices